Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems

References

• Zhang SY, Xu MY, Xu HM, et al. Immunologic characterization of cytokine responses to enterovirus 71 and coxsackievirus A16 infection in children. Medicine (Baltimore). 2015;94:e1137.
   PubMed Web of Science ®Google Scholar
• Kwai Peng C, Kee Tai G, Chia Yin C, et al. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis. 2003;9:78–85.
   PubMed Web of Science ®Google Scholar
• Steven Oberste M, Maher K, Pallansch MA. Evidence for frequent recombination within species human enterovirus B based on complete genomic sequences of all thirty-seven serotypes. J Virol. 2004;78:855–867.
   PubMed Web of Science ®Google Scholar
• Mao Q, Wang Y, Bian L, et al. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases. Emerg Microbes Infect. 2016;5:e75.
   PubMed Web of Science ®Google Scholar
• Palacios G, Oberste MS. Enteroviruses as agents of emerging infectious diseases. J Neurovirol. 2005;11:424–433.
   PubMed Web of Science ®Google Scholar
• Wu Y, Yeo A, Phoon MC, et al. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis. 2010;14:e1076.
   PubMed Web of Science ®Google Scholar
• Bracho MA, Gonzálezcandelas F, Valero A, et al. Enterovirus co-infections and onychomadesis after hand, foot, and mouth disease, Spain, 2008. Emerg Infect Dis. 2011;17:2223–2231.
   PubMed Web of Science ®Google Scholar
• Blomqvist S, Klemola P, Kaijalainen S, et al. Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J Clin Virol. 2010;48:49–54.
   PubMed Web of Science ®Google Scholar
• Dalldorf G. The coxsackie virus group. Ann N Y Acad Sci. 2010;56:583–586.
   Google Scholar
• Mattern CFT, Dubuy HG. Purification and crystallization of coxsackie virus. Science. 1956;123:1037–1038.
   PubMed Web of Science ®Google Scholar
• Fuschino ME, Lamson DM, Rush K, et al. Detection of coxsackievirus A10 in multiple tissues of a fatal infant sepsis case. J Clin Virol. 2012;53:259–261.
   PubMed Web of Science ®Google Scholar
• Okada H, Wada M, Sato H, et al. Neuromyelitis optica preceded by hyperckemia and a possible association with coxsackie virus group A10 infection. Intern Med. 2013;52:2665–2668.
   PubMed Web of Science ®Google Scholar
• Qing-Bin L, Xiao-Ai Z, Ying W, et al. Circulation of Coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009–2011. Plos One. 2012;7:e52073.
   PubMed Web of Science ®Google Scholar
• Shengxiang G, Qiang Y, Shuizhen H, et al. Specific primer amplification of the VP1 region directed by 5ʹ UTR sequence analysis: enterovirus testing and identification in clinical samples from hand-foot-and-mouth disease patients. J Virol Methods. 2013;193:463–469.
   PubMed Web of Science ®Google Scholar
• Gopalkrishna V, Patil PR, Patil GP, et al. Circulation of multiple enterovirus serotypes causing hand, foot and mouth disease in India. J Med Microbiol. 2012;61:420.
   PubMed Web of Science ®Google Scholar
• Tsuey-Li L, Yi-Syue L, Chiao-Wei H, et al. Rapid and highly sensitive coxsackievirus a indirect immunofluorescence assay typing kit for enterovirus serotyping. J Clin Microbiol. 2008;46:785–788.
   PubMed Web of Science ®Google Scholar
• She RC, Preobrazhensky SN, Taggart EW, et al. Flow cytometric detection and serotyping of enterovirus for the clinical laboratory. J Virol Methods. 2009;162:245–250.
   PubMed Web of Science ®Google Scholar
• Dunnebacke TH, Mattern CF. A comparison of the growth properties of coxsackie virus strains A-9 and A-10 with poliovirus strain Mahoney in cultures of primary human amnion cells. J Iimmunol. 1961;86:585–589.
   PubMed Web of Science ®Google Scholar
• Nadkarni SS, Deshpande JM. Recombinant murine L20B cell line supports multiplication of group A coxsackieviruses. J Med Virol. 2003;70:81–85.
   PubMed Web of Science ®Google Scholar
• Itagaki A, Kamahora T, Kurimura T. Isolation and characterization of a cold-sensitive strain of coxsackievirus A10. J Gen Virol. 1987;68(Pt 4):1191.
   PubMedGoogle Scholar
• Miyamoto A, Hirata R, Ishimoto K, et al. An outbreak of hand-foot-and-mouth disease mimicking chicken pox, with a frequent association of onychomadesis in Japan in 2009: a new phenotype caused by coxsackievirus A6. Eur J Dermatol. 1900;24:103–104.
   Google Scholar
• Allan Nix W, Steven Oberste M, Pallansch MA. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol. 2006;44:2698.
   PubMed Web of Science ®Google Scholar
• Yao X, Bian LL, Lu WW, et al. Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013–2014. Hum Vaccines. 2017;13:823–830.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang R, Ou X, et al. Rapid detection of enterovirus and coxsackievirus A10 by a TaqMan based duplex one-step real time RT-PCR assay. Mol Cell Probes. 2017;33:S0890850817300154.
   Web of Science ®Google Scholar
• Yan TF, Li XN, Wang L, et al. Development of a reverse transcription recombinase-aided amplification assay for the detection of coxsackievirus A10 and coxsackievirus A6 RNA. Arch Virol. 2018;163:1455-1461.
   Web of Science ®Google Scholar
• Nguyen AT, Tran TT, Hoang VMT, et al. Development and evaluation of a non-ribosomal random PCR and next-generation sequencing based assay for detection and sequencing of hand, foot and mouth disease pathogens. Virol J. 2016;45:187.
   Google Scholar
• Dalldorf G. THE COXSACKIE VIRUSES1955.
   Google Scholar
• Itagaki A, Ishihara J, Mochida K, et al. A clustering outbreak of hand, foot, and mouth disease caused by coxsackie virus A10. Microbiol Immunol. 2013;27:929–935.
   Google Scholar
• Mirand A, Henquell C, Archimbaud C, et al. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study. Clin Microbiol Infect. 2012;18:E110–E8.
   PubMed Web of Science ®Google Scholar
• Chatproedprai S, Theanboonlers A, Korkong S, et al. Clinical and molecular characterization of hand-foot-and-mouth disease in Thailand, 2008–2009. Jpn J Infect Dis. 2010;63:229–233.
   PubMed Web of Science ®Google Scholar
• Linsuwanon P, Puenpa J, Huang SW, et al. Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations. J Biomed Sci. 2014;21:16.
   PubMed Web of Science ®Google Scholar
• Jiratchaya P, John M, Piyada L, et al. Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012. Plos One. 2014;9:e98888.
   PubMed Web of Science ®Google Scholar
• Upala P, Apidechkul T, Suttana W, et al. Molecular epidemiology and clinical features of hand, foot and mouth disease in northern Thailand in 2016: a prospective cohort study. BMC Infect Dis. 2018;18:630.
   PubMed Web of Science ®Google Scholar
• Kumar A, Shukla D, Kumar R, et al. Molecular identification of enteroviruses associated with aseptic;meningitis in children from India. Arch Virol. 2013;158:211–215.
   PubMed Web of Science ®Google Scholar
• Ya-Qing H, Long C, Wen-Bo X, et al. Emergence, circulation, and spatiotemporal phylogenetic analysis of coxsackievirus a6- and coxsackievirus a10-associated hand, foot, and mouth disease infections from 2008 to 2012 in Shenzhen, China. J Clin Microbiol. 2013;51:3560–3566.
   PubMed Web of Science ®Google Scholar
• Xu M, Su L, Cao L, et al. Enterovirus genotypes causing hand foot and mouth disease in Shanghai, China: a molecular epidemiological analysis. BMC Infect Dis. 2013;13:489.
   PubMed Web of Science ®Google Scholar
• Xu M, Su L, Cao L, et al. Genotypes of the enterovirus causing hand foot and mouth disease in Shanghai, China, 2012–2013. Plos One. 2015;10:e0138514.
   PubMed Web of Science ®Google Scholar
• Wang J, Teng Z, Cui X, et al. Epidemiological and serological surveillance of hand-foot-and-mouth disease in Shanghai, China, 2012–2016. Emerg Microbes Infect. 2018;7:8.
   PubMed Web of Science ®Google Scholar
• Li J, Hao P, Wang X, et al. Epidemiological surveillance of hand, foot and mouth disease in Shanghai in 2014–2016, prior to the introduction of the enterovirus 71 vaccine. Emerg Microbes Infect. 2018;7:37.
   PubMed Web of Science ®Google Scholar
• Yun H, Yuanping Z, Hong L, et al. Characterization of severe hand, foot, and mouth disease in Shenzhen, China, 2009–2013. J Med Virol. 2015;87:1471–1479.
   PubMed Web of Science ®Google Scholar
• Tian H, Zhang Y, Shi Y, et al. Epidemiological and aetiological characteristics of hand, foot, and mouth disease in Shijiazhuang City, Hebei province, China, 2009–2012. Plos One. 2017;12:e0176604.
   PubMed Web of Science ®Google Scholar
• Li Y, Bao H, Zhang X, et al. Epidemiological and genetic analysis concerning the non-enterovirus 71 and non-coxsackievirus A16 causative agents related to hand, foot and mouth disease in Anyang City, Henan Province, China, from 2011 to 2015. J Med Virol. 2017;89:1749-1758.
   Web of Science ®Google Scholar
• Huifang T, Yong Z, Qiang S, et al. Prevalence of multiple enteroviruses associated with hand, foot, and mouth disease in Shijiazhuang City, Hebei province, China: outbreaks of coxsackieviruses a10 and b3. Plos One. 2014;9:e84233.
   PubMed Web of Science ®Google Scholar
• Chen JF, Zhang RS, Ou XH, et al. The role of enterovirus 71 and coxsackievirus A strains in a large outbreak of hand, foot, and mouth disease in 2012 in Changsha, China. Inter J Infect Dis. 2014;28:17–25.
   PubMed Web of Science ®Google Scholar
• Wen-Ping G, Xian-Dan L, Yi-Ping C, et al. Fourteen types of co-circulating recombinant enterovirus were associated with hand, foot, and mouth disease in children from Wenzhou, China. J Clin Virol. 2015;70:29–38.
   PubMed Web of Science ®Google Scholar
• Qin Y, Jinya D, Junhao C, et al. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: outbreaks of coxsackieviruses A10. J Med Virol. 2015;87:954–960.
   PubMed Web of Science ®Google Scholar
• He SZ, Chen MY, Xu XR, et al. Epidemics and aetiology of hand, foot and mouth disease in Xiamen, China, from 2008 to 2015. Epidemiol Infect. 2017;145:1.
   PubMed Web of Science ®Google Scholar
• Chen M, He S, Yan Q, et al. Severe hand, foot and mouth disease associated with Coxsackievirus A10 infections in Xiamen, China in 2015. J Clin Virol. 2017;93:20.
   PubMed Web of Science ®Google Scholar
• Yamashita T, Ito M, Taniguchi A, et al. Prevalence of coxsackievirus A5, A6, and A10 in patients with herpangina in Aichi Prefecture, 2005. Jpn J Infect Dis. 2005;58:390–391.
   PubMed Web of Science ®Google Scholar
• Fuschino ME, Lamson DM, Kimberley R, et al. Detection of coxsackievirus A10 in multiple tissues of a fatal infant sepsis case. J Clin Virol. 2012;53:259–261.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhu R, Yang Y, et al. Phylogenetic analysis of the major causative agents of hand, foot and mouth disease in Suzhou city, Jiangsu province, China, in 2012–2013. Emerg Microbes Infect. 2015;4:e12.
   PubMed Web of Science ®Google Scholar
• Jiang FC, Yang F, Chen L, et al. Meteorological factors affect the hand, foot, and mouth disease epidemic in Qingdao, China, 2007–2014. Epidemiol Infect. 2016;144:2354–2362.
   PubMed Web of Science ®Google Scholar
• B’Krong NTTC, Minh NNQ, Qui PT, et al. Enterovirus serotypes in patients with central nervous system and respiratory infections in Viet Nam 1997–2010. Virol J. 2018;15:69.
   PubMed Web of Science ®Google Scholar
• Guan H, Wang J, Wang C, et al. Etiology of multiple Non-EV71 and Non-CVA16 enteroviruses associated with hand, foot and mouth disease in Jinan, China, 2009-June 2013. Plos One. 2015;10:e0142733.
   PubMed Web of Science ®Google Scholar
• Oberste MS, Penaranda SK, Pallansch MA. Complete genome sequences of all members of the species Human enterovirus A. J Gen Virol. 2004;85:1597.
   PubMed Web of Science ®Google Scholar
• Oberste MS, Maher K, Kilpatrick DR, et al. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol. 1999;73:1941.
   PubMed Web of Science ®Google Scholar
• Oberste MS, Maher K, Kennett ML, et al. Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation. J Clin Microbiol. 1999;37:3928.
   PubMed Web of Science ®Google Scholar
• Palacios G, Casas I, Cisterna D, et al. Molecular epidemiology of echovirus 30: temporal circulation and prevalence of single lineages. J Virol. 2002;76:4940.
   PubMed Web of Science ®Google Scholar
• Oberste M, Schnurr D, Maher K, et al. Molecular identification of new picornaviruses and characterization of a proposed enterovirus 73 serotype. J Gen Virol. 2001;82:409–416.
   PubMed Web of Science ®Google Scholar
• Lukashev AN, Elena YS, Belalov IS, et al. Recombination strategies and evolutionary dynamics of the human enterovirus A global gene pool. J Gen Virol. 2014;95:868–873.
   PubMed Web of Science ®Google Scholar
• Volle R, Razafindratsimandresy R, Joffret ML, et al. High permissiveness for genetic exchanges between enteroviruses of species A, including enterovirus 71, favours evolution through intertypic recombination in Madagascar. J Virol. 2019.
   PubMed Web of Science ®Google Scholar
• Zhu R, Cheng T, Yin Z, et al. Serological survey of neutralizing antibodies to eight major enteroviruses among healthy population. Emerg Microbes Infect. 2018;7:2.
   PubMed Web of Science ®Google Scholar
• Fu Y, Sun SY, Mao QY, et al. Seroepidemiology of coxsackievirus A10 infection in infants and children: a prospective cohort study in Jiangsu, China. J Infect. 2018;77:158–164.
   PubMed Web of Science ®Google Scholar
• Gao F, Mao QY, Chen P, et al. Seroepidemiology of coxsackievirus A6, coxsackievirus A16, and Enterovirus 71 infections in infants and children: a prospective cohort study in Jiangsu, China. J Infect. 2016;73:509–512.
   PubMed Web of Science ®Google Scholar
• Li S, Zhao H, Yang L, et al. A neonatal mouse model of coxsackievirus A10 infection for anti-viral evaluation. Antiviral Res. 2017;144:247–255.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Dong Z, Li J, et al. Protective efficacies of formaldehyde-inactivated whole-virus vaccine and antivirals in a murine model of coxsackievirus A10 infection. J Virol. 2017;91:e00333-17.
   Web of Science ®Google Scholar
• Xu L, He D, Yang L, et al. A broadly cross-protective vaccine presenting the neighboring epitopes within the VP1 GH loop and VP2 EF loop of enterovirus 71. Sci Rep. 2015;5:12973.
   PubMed Web of Science ®Google Scholar
• Shiyang S, Liping J, Zhenglun L, et al. Evaluation of monovalent and bivalent vaccines against lethal enterovirus 71 and coxsackievirus A16 infection in newborn mice. Hum Vaccines. 2014;10:2885–2895.
   Web of Science ®Google Scholar
• Lin CW, Liu CC, Lu TC, et al. Immunogenicity studies of bivalent inactivated virions of EV71/CVA16 formulated with submicron emulsion systems. J Biomed Biotechnol. 2014;2014:670506.
   Google Scholar
• Zhao H, Li HY, Han JF, et al. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice. Sci Rep. 2015;5:7878.
   PubMed Web of Science ®Google Scholar
• Klein MH. EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines. Expert Rev Vaccines. 2015;14:337–340.
   PubMed Web of Science ®Google Scholar
• Aswathyraj S, Arunkumar G, Alidjinou EK, et al. Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy. Med Microbiol Immunol. 2016;205:397–407.
   PubMed Web of Science ®Google Scholar
• Klein M, Chong P. Is a multivalent hand, foot, and mouth disease vaccine feasible? Hum Vaccines. 2015;11:2688–2704.
   PubMed Web of Science ®Google Scholar
• Shen C, Liu Q, Zhou Y, et al. Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge. Vaccine. 2016;34:5005–5012.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang C, Liu Q, et al. A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection. Antiviral Res. 2018;152:S0166354217307131.
   Web of Science ®Google Scholar
• Liu CC, Guo MS, Wu SR, et al. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles. Antiviral Res. 2016;129:58–66.
   PubMed Web of Science ®Google Scholar
• Mendelsohn CL, Wimmer E, Racaniello VR. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell. 1989;56:855–865.
   PubMed Web of Science ®Google Scholar
• Ren R, Costantini F, Gorgacz EJ, et al. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell. 1990;63:353–362.
   PubMed Web of Science ®Google Scholar
• Tan CW, Lai JKF, Sam IC, et al. Recent developments in antiviral agents against enterovirus 71 infection. J Biomed Sci. 2014;21:14.
   PubMed Web of Science ®Google Scholar
• Staring J, Hengel LGVD, Raaben M, et al. KREMEN1 is a host entry receptor for a major group of enteroviruses. Cell Host Microbe. 2018;23:636.
   PubMed Web of Science ®Google Scholar
• Lu J, Zeng H, Zheng H, et al. Hand, foot and mouth disease in Guangdong, China, in 2013: new trends in the continuing epidemic. Clin Microbiol Infect. 2014;20:O442–O5.
   PubMed Web of Science ®Google Scholar
• Davia JL, Bel PH, Ninet VZ, et al. Onychomadesis outbreak in Valencia, Spain associated with hand, foot, and mouth disease caused by enteroviruses. Pediatr Dermatol. 2011;28:1–5.
   PubMed Web of Science ®Google Scholar
• Pons-Salort M, Parker EP, Grassly NC. The epidemiology of non-polio enteroviruses: recent advances and outstanding questions. Curr Opin Infect Dis. 2015;28:479.
   PubMed Web of Science ®Google Scholar
• Cai Y, Liu Q, Huang X, et al. Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection. Vaccine. 2013;31:2215–2221.
   PubMed Web of Science ®Google Scholar
• Ku Z, Liu Q, Ye X, et al. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice. Vaccine. 2014;32:4296–4303.
   PubMed Web of Science ®Google Scholar
• Zhu L, Sun Y, Fan J, et al. Structures of coxsackievirus A10 unveil the molecular mechanisms of receptor binding and viral uncoating. Nat Commun. 2018;9:4985.
   PubMed Web of Science ®Google Scholar